Want to join the conversation?
For 2016, $ESS expects expense growth of 3.8%. The NOI growth is expected to be 8.1% at the midpoint. The projected reduction to same property growth rate is approx. $0.05 per share to the full-year core FFO. The company has raised its full-year core FFO midpoint by $0.06 per share to $10.98. For 2016, $ESS expects core FFO growth of 12%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?